Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Srgap2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRGAP2 mRNA | CTD | PMID:22079256 | Srgap2 | Rat | (S)-nicotine | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Nicotine results in decreased expression of SRGAP2 mRNA | CTD | PMID:17997037 | Srgap2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Srgap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Srgap2 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Srgap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Srgap2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SRGAP2 mRNA | CTD | PMID:32109520 and PMID:34747641 | Srgap2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | Srgap2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SRGAP2 mRNA | CTD | PMID:30851411 | Srgap2 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of SRGAP2 protein | CTD | PMID:34915118 | Srgap2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SRGAP2 mRNA | CTD | PMID:28973697 | Srgap2 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SRGAP2 mRNA | CTD | PMID:31881176 | Srgap2 | Rat | acrolein | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SRGAP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SRGAP2 mRNA | CTD | PMID:32699268 | Srgap2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SRGAP2 mRNA | CTD | PMID:28959563 | Srgap2 | Rat | alpha-pinene | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SRGAP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SRGAP2 mRNA | CTD | PMID:32699268 | Srgap2 | Rat | antirheumatic drug | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SRGAP2 mRNA | CTD | PMID:24449571 | Srgap2 | Rat | arachidonic acid | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Arachidonic Acid results in decreased expression of SRGAP2 mRNA | CTD | PMID:16704987 | Srgap2 | Rat | arsenite(3-) | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SRGAP2 mRNA] | CTD | PMID:32406909 | Srgap2 | Rat | benzo[a]pyrene | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SRGAP2 mRNA | CTD | PMID:19770486 | Srgap2 | Rat | benzo[a]pyrene | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SRGAP2 mRNA | CTD | PMID:20064835 more ... | Srgap2 | Rat | beta-lapachone | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of SRGAP2 mRNA | CTD | PMID:38218311 | Srgap2 | Rat | bisphenol A | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SRGAP2 mRNA | CTD | PMID:25047013 | Srgap2 | Rat | bisphenol A | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SRGAP2 mRNA | CTD | PMID:33670352 | Srgap2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SRGAP2 mRNA | CTD | PMID:30816183 more ... | Srgap2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SRGAP2 mRNA | CTD | PMID:25181051 | Srgap2 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of SRGAP2 mRNA | CTD | PMID:19167457 | Srgap2 | Rat | cadmium dichloride | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of SRGAP2 mRNA | CTD | PMID:38568856 | Srgap2 | Rat | caffeine | affects phosphorylation | ISO | SRGAP2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SRGAP2 protein | CTD | PMID:35688186 | Srgap2 | Rat | calcitriol | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SRGAP2 mRNA | CTD | PMID:16002434 | Srgap2 | Rat | CGP 52608 | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SRGAP2 gene] | CTD | PMID:28238834 | Srgap2 | Rat | cisplatin | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SRGAP2 mRNA | CTD | PMID:19561079 | Srgap2 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of SRGAP2 mRNA | CTD | PMID:24386269 | Srgap2 | Rat | copper(II) sulfate | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SRGAP2 mRNA | CTD | PMID:19549813 | Srgap2 | Rat | CU-O LINKAGE | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of SRGAP2 mRNA | CTD | PMID:22077320 | Srgap2 | Rat | cyclosporin A | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of SRGAP2 mRNA | CTD | PMID:19770486 | Srgap2 | Rat | Dibutyl phosphate | affects expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SRGAP2 mRNA | CTD | PMID:37042841 | Srgap2 | Rat | dicrotophos | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of SRGAP2 mRNA | CTD | PMID:28302478 | Srgap2 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of SRGAP2 mRNA | CTD | PMID:25152437 | Srgap2 | Rat | dorsomorphin | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRGAP2 mRNA | CTD | PMID:27188386 | Srgap2 | Rat | doxorubicin | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SRGAP2 mRNA | CTD | PMID:29803840 | Srgap2 | Rat | enzyme inhibitor | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRGAP2 protein | CTD | PMID:23301498 | Srgap2 | Rat | ethanol | affects expression | ISO | Srgap2 (Mus musculus) | 6480464 | Ethanol affects the expression of SRGAP2 mRNA | CTD | PMID:30319688 | Srgap2 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of SRGAP2 mRNA | CTD | PMID:34044035 | Srgap2 | Rat | hydrogen peroxide | affects expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SRGAP2 mRNA | CTD | PMID:20044591 | Srgap2 | Rat | ivermectin | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SRGAP2 protein | CTD | PMID:32959892 | Srgap2 | Rat | lead(0) | affects expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Lead affects the expression of SRGAP2 mRNA | CTD | PMID:28903495 | Srgap2 | Rat | melphalan | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of SRGAP2 mRNA | CTD | PMID:22363485 | Srgap2 | Rat | menadione | affects expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of SRGAP2 mRNA | CTD | PMID:20044591 | Srgap2 | Rat | methamphetamine | increases methylation | ISO | Srgap2 (Mus musculus) | 6480464 | Methamphetamine results in increased methylation of SRGAP2 promoter | CTD | PMID:26307267 | Srgap2 | Rat | methamphetamine | increases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of SRGAP2 mRNA | CTD | PMID:26307267 | Srgap2 | Rat | methidathion | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | methidathion results in decreased expression of SRGAP2 mRNA | CTD | PMID:34813904 | Srgap2 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SRGAP2 gene | CTD | PMID:35440735 | Srgap2 | Rat | methylmercury chloride | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SRGAP2 mRNA | CTD | PMID:28001369 | Srgap2 | Rat | nickel atom | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of SRGAP2 mRNA | CTD | PMID:25583101 | Srgap2 | Rat | nicotine | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Nicotine results in decreased expression of SRGAP2 mRNA | CTD | PMID:17997037 | Srgap2 | Rat | ozone | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SRGAP2 mRNA more ... | CTD | PMID:32699268 | Srgap2 | Rat | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of SRGAP2 mRNA | CTD | PMID:35737395 | Srgap2 | Rat | paracetamol | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SRGAP2 mRNA | CTD | PMID:22230336 more ... | Srgap2 | Rat | PCB138 | multiple interactions | ISO | Srgap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Srgap2 | Rat | potassium chromate | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SRGAP2 mRNA | CTD | PMID:22079256 | Srgap2 | Rat | potassium chromate | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRGAP2 mRNA | CTD | PMID:22079256 | Srgap2 | Rat | rac-lactic acid | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SRGAP2 mRNA | CTD | PMID:30851411 | Srgap2 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SRGAP2 mRNA | CTD | PMID:19013527 | Srgap2 | Rat | SB 431542 | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRGAP2 mRNA | CTD | PMID:27188386 | Srgap2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SRGAP2 mRNA | CTD | PMID:19281266 | Srgap2 | Rat | titanium dioxide | decreases methylation | ISO | Srgap2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SRGAP2 gene | CTD | PMID:35295148 | Srgap2 | Rat | triacsin C | decreases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | triacsin C results in decreased expression of SRGAP2 mRNA | CTD | PMID:16704987 | Srgap2 | Rat | trichostatin A | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SRGAP2 mRNA | CTD | PMID:24935251 | Srgap2 | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of SRGAP2 mRNA | CTD | PMID:30589522 | Srgap2 | Rat | triptonide | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | triptonide results in decreased expression of SRGAP2 mRNA | CTD | PMID:33045310 | Srgap2 | Rat | tungsten | decreases expression | ISO | Srgap2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of SRGAP2 mRNA | CTD | PMID:30912803 | Srgap2 | Rat | urethane | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Urethane results in increased expression of SRGAP2 mRNA | CTD | PMID:28818685 | Srgap2 | Rat | valproic acid | increases expression | ISO | SRGAP2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SRGAP2 mRNA | CTD | PMID:23179753 and PMID:26272509 | Srgap2 | Rat | valproic acid | multiple interactions | ISO | SRGAP2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRGAP2 mRNA | CTD | PMID:27188386 | |